Concepedia

Rahul Argula

RA

Statistics

Publications

14

Citations

1.1K

H-Index

12

Active since

2013

Affiliations

Medical University of South Carolina(Current)

United Therapeutics (United States)

Brigham and Women's Hospital

Cedars-Sinai Medical Center

Triangle

Rahul Argula is an author at Medical University of South Carolina specializing in medicine, pulmonology, and pulmonary hypertension.

ORCID

Publications per year

2013–2024

14

Publications

14

Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease

Aaron B. Waxman, Ricardo Restrepo‐Jaramillo, Thenappan Thenappan et al. · New England Journal of Medicine · 2021 · 614 citations · Full text

, , +14

Rare variant analysis of 4241 pulmonary arterial hypertension cases from an international consortium implicates FBLN2, PDGFD, and rare de novo variants in PAH

Na Zhu, Emilia M. Swietlik, Carrie L. Welch et al. · Genome Medicine · 2021 · 85 citations · Full text

, , +17

Long-term inhaled treprostinil for pulmonary hypertension due to interstitial lung disease: INCREASE open-label extension study

Aaron B. Waxman, Ricardo Restrepo‐Jaramillo, Thenappan Thenappan et al. · European Respiratory Journal · 2023 · 65 citations · Full text

, , +10

Inhaled treprostinil in pulmonary hypertension associated with COPD: PERFECT study results

Steven D. Nathan, Rahul Argula, Maria Giovanna Trivieri et al. · European Respiratory Journal · 2024 · 63 citations · Full text

, , +14

Bayesian Inference Associates Rare <i>KDR</i> Variants With Specific Phenotypes in Pulmonary Arterial Hypertension

Daniel Greene, Na Zhu, Karyn Mégy et al. · Circulation Genomic and Precision Medicine · 2020 · 47 citations · Full text

, , +17

1–5 of 14